Participants
inflammation
INFLAMMATION
A requirement of the parent study (MedCan-1) was the provision of a blood sample for CRP analysis at baseline, days 14, and 28. Additionally, a subset of participants (from those recruited through Mater Health Services only) were asked to consent to the inflammation sub-study (MedCan-Inflam) in which they were required to provide extra blood samples for analysis of inflammatory cytokines along with the required collection of blood for CRP measurement.Participants remained on all their regular medications including anti-cancer therapy. Concomitant medication use was recorded and included in the analysis.